Isocyanate-induced occupational asthma: immunologic and challenge studies. |
Jung Eun Suh1, Hae Sim Park2, Seong Jin Kim2, Nam Soo Rhu2, Dong Ill Cho2, Jae Won Kim2, Nan Ho Kyung3 |
1Department of Chest Medicine, Seoul Seodaemoon City Hospital, Seoul, Korea 2Department of Chest Medicine, National Medical Center, Seoul, Korea 3Department of Internal Medicine, Ewha UniverSity College of Medicine, Seoul, Korea |
|
Abstract |
Background Isocyanate is the most significant cause of occupational asthma in this country. The mechanism of isocyanate induced bronchoconstriction is unclear.
Subjects and Methods: To observe its immunologic and clinical findings, we performed methacholine bronchial challenge test (MBCT), toluene diisocyanate (TDI).bronchoprovocation test (BPT) and RAST to TDI-, diphenylmethane diisocyanate (MDI)-, and hexamethylene diisocyanate (HDI)-human serum albumin (HSA) conjugate in 22 isocyanate-sensitive asthmatic workers.
Results BPT revealed early (11), dual (5), and late only (6) asthmatic responses. Their latent period ranged from 3 to 120 months (mean:45. 9 months). Three cases (13 . 6%)showed a negative response on initial MBCT, but following MBCT performed 24 hours after TDI-BPT revealed the development of airway hyperresponsiveness. Twelve (54 .5%) workers had increased specific IgE to TDI-HSA, seven (31. 8%) had to MDI-HSA, and nine (40.9%) had to HDI-HSA conjugate. The prevalence of specific IgE was not associated with latent period, type of asthmatic responses, smoking, and atopic status.
After 3 months, avoidance from workplace, airway hyperresponsiveness was improved in 10 (38 .3%) among 12 followed cases.
Conclusions It is suggested that isocyanate can induce IgE-mediated bronchoconstriction in 59 _1 % of isocyanate-sensitive asthmatic workers. Isocyanate-induced asthma can occur even though MBCT showed a negative result, and measurement of the changes of airway hyperresponsiveness after isocyanate-BPT could be helpful to diagnose isocyanate-sensitive asthma. |
Key Words:
Occupational asthma, Methacholine bronchial challenge test, Toluene diisocyanate, Specific IgE antibody |
|